BioAegis accelerated multiple clinical trial submissions for severe COVID-19 pneumonia patients
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
On Apr. 2, 2020, BioAegis Therapeutics announced that it was preparing to evaluate plasma gelsolin replacement in severe…
On Apr. 2, 2020, Roswell Park Comprehensive Cancer Center and the University at Buffalo (UB) launched a collaborative…
On Apr. 2, 2020, George Washington University Hospital announed it had used Virtual Reality technology to see into…
On Apr. 2, 2020, Amgen and Adaptive Biotechnologies announced a collaboration aimed at helping address the COVID-19 pandemic….
On Apr. 2, 2020, an international collaboration of virologists at the University of Wisconsinï¾–Madison and the vaccine companies…
On Apr. 1, 2020, Philips announced that it can help general practitioners and healthcare institutions manage the increased…
On Apr. 1, 2020, Innovation Pharma it had received data supporting Brilacidinï¾’s direct inhibition of SARS-CoV-2, the novel…
On Apr. 1, 2020, Henry Schein announced that it will serve as the exclusive distributor in the U.S….
On Apr. 1, 2020, Diffusion Pharmaceuticals announced it had begun a cooperative research effort with University of Virginia…
On Apr. 1, 2020, a study of 24 of the most critically ill patients with COVID-19, early on…
On Mar. 31, 2020, FUJIFILM announced initiation of a phase III clinical trial to evaluate the safety and…
On Mar. 31, 2020, Vaxart announced it had produced five COVID-19 vaccine candidates for testing in its preclinical…
On Mar. 31, 2020, Sorrento announced it had entered into a research testing agreement with The University of…
On Mar. 31, 2020, Kleo Pharmaceuticals announced it had entered into a research collaboration with South Korea -based…
On Mar. 31, 2020, Mayo Clinic in Florida announced it had significantly ramped up efforts to process and…
On Mar. 31, 2020, BD (Becton, Dickinson and Company) and BioMedomics announced the release of a new point-of-care…
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
On Mar. 31, 2020, VBI Vaccines announced a collaboration with the National Research Council of Canada (NRC) to…
On Mar. 30, 2020, the Military Sealift Command hospital ship USNS Comfort to join COVID-19 fight in New…
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
On Mar. 30, 2020, the Institute for Molecular Medicine in Finland (FIMM) announced it had launched a COVID-19…
On Mar. 30, 2020 Medtronic announced it was publicly sharing the design specifications for the Puritan Bennett 560…
On Mar. 30, 2020, the partners in the COVID-19 Therapeutics Accelerator announced grants of $20 million to three…
On Mar. 30, 2020, the Translational Genomics Research Institute (TGen) announced that it had joined the world-wide effort…
On Mar. 30, 2020, Humanigen announced that the company had submitted an initial protocol synopsis to the FDA…
On Mar. 30, 2020, Altimmune announced that it was launching a collaboration with the University of Alabama at…
On Mar. 30, 2020, researchers from the University of Minnesota broke new ground in understanding how SARS-CoV-2, the…
On Mar. 30, 2020, Johnson & Johnson announced the selection of a lead COVID-19 vaccine candidate from constructs…
On Mar. 30, 2020, Bellerophon Therapeutics announced that expanded access treatment with the INOpulse inhaled nitric oxide system…
On Mar. 29, 2020, a study by UNMC/Nebraska Medicine/NSRI researchers provides new evidence of SARS-CoV-2 environmental contamination in…